Fingerprint
Dive into the research topics of 'The design of phase II clinical trials testing cancer therapeutics: Consensus recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically